Christoph Röcken

Dr. Christoph Röcken

Christian-Albrechts-Universität zu Kiel, Germany
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SHSteve Horvath
Steve Horvath
WEWiebke Erhart
Wiebke Erhart
MBMario Brosch
Mario Brosch
OAOle Ammerpohl
Ole Ammerpohl
WSWitigo von Schönfels
Witigo von Schönfels
JHJochen Hampe
Jochen Hampe
Because of the dearth of biomarkers of aging, it has been difficult to test the hypothesis that obesity increases tissue age. Here we use a novel epigenetic biomarker of aging (referred to as an “epigenetic clock”) to study the relationship between high body mass index (BMI) and the DNA methylation ages of human blood, liver, muscle, and adipose tissue. A significant correlation between BMI and epigenetic age acceleration could only be observed for liver (r = 0.42, P = 6.8 × 10−4 in dataset 1 and r = 0.42, P = 1.2 × 10−4 in dataset 2). On average, epigenetic age increased by 3.3 y for each 10 BMI units. The detected age acceleration in liver is not associated with the Nonalcoholic Fatty Liver Disease Activity Score or any of its component traits after adjustment for BMI. The 279 genes that are underexpressed in older liver samples are highly enriched (1.2 × 10−9) with nuclear mitochondrial genes that play a role in oxidative phosphorylation and electron transport. The epigenetic age acceleration, which is not reversible in the short term after rapid weight loss induced by bariatric surgery, may play a role in liver-related comorbidities of obesity, such as insulin resistance and liver cancer. Significance Because obese people are at an increased risk of many age-related diseases, it is a plausible hypothesis that obesity increases the biological age of some tissues and cell types. However, it has been difficult to detect such an accelerated aging effect because it is unclear how to measure tissue age. Here we use a recently developed biomarker of aging (known as “epigenetic clock”) to study the relationship between epigenetic age and obesity in several human tissues. We report an unexpectedly strong correlation between high body mass index and the epigenetic age of liver tissue. This finding may explain why obese people suffer from the early onset of many age-related pathologies, including liver cancer.

1 August 2013 in Cell Metabolism
Verified
Journal Article
Closed access
MAMarkus Ahrens
Markus Ahrens
OAOle Ammerpohl
Ole Ammerpohl
WSWitigo von Schönfels
Witigo von Schönfels
JKJulia Kolarova
Julia Kolarova
SBSusanne Bens
Susanne Bens
JHJochen Hampe
Jochen Hampe

1 May 2000 in JACC
Verified
Journal Article
Closed access
AGAndreas Goette
Andreas Goette
TSThorsten Staack
Thorsten Staack
CRChristoph Röcken
Christoph Röcken
MAMarco Arndt
Marco Arndt
JGJ.CHristoph Geller
J.CHristoph Geller
ULUwe Lendeckel
Uwe Lendeckel

8 July 2008 in Cancer
Verified
Journal Article
Open access
PDF file
UPUlrich‐Frank Pape
Ulrich‐Frank Pape
HJHenning Jann
Henning Jann
JMJacqueline Müller‐Nordhorn
Jacqueline Müller‐Nordhorn
ABAngelina Bockelbrink
Angelina Bockelbrink
UBUta Berndt
Uta Berndt
BWBertram Wiedenmann
Bertram Wiedenmann
BACKGROUND.: Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a rare but challenging group of malignant neoplasms and occur at virtually any site of the GEP system. In 2006, a new TNM classification system was proposed for the staging and grading of upper GEP NETs.METHODS.: The prognostic relevance of the TNM classification system was analyzed retrospectively in 202 patients from a referral center with histologically proven foregut NET. Patients were classified according to previous classification systems and the TNM classification. Survival data were acquired and statistical analyses were performed by using log‐rank and Cox regression testing.RESULTS.: Primary tumors were gastric (n = 48), duodenal (n = 23), and pancreatic (n = 131). During the observation period, 21% of patients died. The overall 5‐ and 10‐year survival rates were 75% and 64%, respectively. Previous classification systems discriminated between low‐grade and high‐grade malignant NETs but did not allow further prognostic differentiation. In contrast, the proposed TNM classification was able to differentiate significantly between different tumor stages (stages I‐III vs stage IV; P < .01) and cellular proliferation rates according to Ki‐67 labeling (grade 1 vs grade 2, P = .04; grade 1 vs grade 3 and grade 2 vs grade 3, P < .01). Cox regression analysis confirmed an increased risk of reduced survival for patients with stage III or IV NET and grade 2 or 3 NET.CONCLUSIONS.: The current results demonstrated the prognostic relevance of the newly proposed TNM classification system for foregut NETs with statistical significance for the subgroups of both the staging classification and the grading system. Thus, the new classification system provides a valid and powerful tool for prognostic stratification of GEP NETs in clinical practice and research. Cancer 2008. © 2008 American Cancer Society.

1 February 2008 in The Lancet Oncology
Verified
Journal Article
Closed access
WWWilko Weichert
Wilko Weichert
ARAnnika Röske
Annika Röske
VGVolker Gekeler
Volker Gekeler
TBThomas Beckers
Thomas Beckers
MEMatthias Pa Ebert
Matthias Pa Ebert
CRChristoph Röcken
Christoph Röcken

1 November 2014 in Gastroenterology
Verified
Journal Article
Open access
PDF file
AFAnnette Fritscher-Ravens
Annette Fritscher-Ravens
DSDetlef Schuppan
Detlef Schuppan
MEMark Ellrichmann
Mark Ellrichmann
SSStefan Schoch
Stefan Schoch
CRChristoph Röcken
Christoph Röcken
PMPeter J. Milla
Peter J. Milla
We investigated suspected food intolerances in patients with irritable bowel syndrome (IBS) using confocal laser endomicroscopy (CLE) for real-time visualization of structural/functional changes in the intestinal mucosa after food challenge. Patients with functional changes after food challenge (CLE+) were placed on personalized exclusion diets and followed up for long-term symptom relief. Thirty-six IBS patients with suspected food intolerance and 10 patients with Barrett’s esophagus (controls) without IBS symptoms were examined by CLE at University Hospital Schleswig-Holstein (Kiel, Germany). Diluted food antigens were administered directly to the duodenal mucosa through the working channel of the endoscope. Epithelial breaks, intervillous spaces, and the number of intraepithelial lymphocytes (IEL) were measured before and after the food challenge. CLE+ patients were placed on exclusion diets, given symptom score questionnaires, and followed up for 1 year; controls resumed their previous diet. CLE showed a real-time response to food antigens in 22 of 36 patients; no responses were observed in 14 of 36 patients (CLE-) or any of the controls. Baseline IELs were significantly higher in CLE+ than CLE- subjects (P = .004); numbers increased significantly after food challenge (P = .0008). Within 5 minutes of exposure of CLE+ patients to food antigens, IELs increased, epithelial leaks/gaps formed, and intervillous spaces widened. Epithelial leaks and intervillous spaces also increased significantly in CLE+ vs baseline (both P < .001). The concordance of IELs measured by CLE and conventional histology was 70.6%; they did not correlate (P = .89; r2 = 0.027). Symptom scores improved more than 50% in CLE+ patients after a 4-week exclusion diet and increased to 74% at 12 months; symptoms continued in CLE- patients. Based on CLE analysis of IBS patients with a suspected food intolerance, exposure to candidate food antigens caused immediate breaks, increased intervillous spaces, and increased IELs in the intestinal mucosa. These changes are associated with patient responses to exclusion diets. Registered at clinicaltrials.gov (registration number: NCT01692613).